We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
+24.08%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
AUM
$214M
AUM Growth
+$9.18M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
1
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.95%
2 Miscellaneous 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$154M 72.03%
1,111,111
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$46.9M 21.9%
9,166,667
EPZM
3
CALL
DELISTED
Epizyme, Inc
EPZM
$13M 6.05%
2,532,048
+4,312
+0.2% +$26.2K
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$30K 0.01%
3,700

Similar funds

RP Management's Q3 2021 Portfolio in Review

As of Q3 2021, RP Management held 4 positions worth $214M, up 4.5% from $205M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 90% a quarter earlier, followed by Miscellaneous.

  • RP Management's ten largest holdings make up 100% of its $214M portfolio in Q3 2021.
  • RP Management opened 0 new positions and closed 0 in Q3 2021.
  • RP Management's portfolio value rose 4.5% quarter-over-quarter to $214M.

Based on RP Management's 13F filing for Q3 2021, filed 15 Nov 2021.